Tens razão, peço desculpa. Aqui vai a tradução completa em texto simples:
Under the tagline "Have you ever imagined what it's like to live hungry 24 hours a day?", SPW Association (Prader-Willi Syndrome) Portugal and Born created the visual identity and multimedia communication campaign for the first national conference dedicated to Prader-Willi Syndrome, scheduled for 8 October 2026.
The SPW Association challenged Born to raise awareness of this rare genetic condition, on the occasion of the first national conference dedicated to the subject. The work includes the event identity and an awareness film for social media and TV. The starting point was listening. The team met and spoke with people with PWS and their families, followed their daily lives, and gathered testimonies of what it means to live with this condition.
Produced by Mother and based on real stories, the campaign portrays the daily life of a grandmother welcoming her granddaughter to her home. Through small everyday details — preparing an afternoon snack ahead of the visit — the campaign shows us what it means to live with and care for someone with this condition.
On 8 October 2026, specialists, healthcare professionals, families, and associations will come together for the first conference dedicated to Prader-Willi Syndrome in Portugal.
Although there is no cure for PWS, new therapeutic options aimed at promoting a sense of satiety are already beginning to transform the lives of people living with the condition. This conference seeks to foster an informed discussion about scientific advances and the challenges that remain.
Prader-Willi Syndrome is a rare and complex genetic condition that affects multiple body systems. One of its most characteristic and debilitating manifestations is hyperphagia — a persistent sense of hunger coupled with the absence of an adequate satiety response — with significant consequences for the health, autonomy, and quality of life of those affected and their families. In recent years, international research has been opening new therapeutic avenues targeting some of the most difficult-to-manage symptoms of PWS, making the discussion around scientific progress, clinical practice, and access to innovation especially timely.
